Multivariate analysis of risk factors for urinary 3-IS levels between days 0 and 10 after ASCT
| . | Multivariate analysis (HR, 95% CI) . | P . |
|---|---|---|
| Gut decontamination: rifaximin vs Cipro/Metro | 0.3 (0.1-0.7) | .01 |
| Systemic antibiotics before ASCT: without or with | 0.1 (0.1-0.3) | <.0001 |
| NOD2/CARD15 genotype: wild type/risk allele | 0.3 (0.1-1.0) | .04 |
| . | Multivariate analysis (HR, 95% CI) . | P . |
|---|---|---|
| Gut decontamination: rifaximin vs Cipro/Metro | 0.3 (0.1-0.7) | .01 |
| Systemic antibiotics before ASCT: without or with | 0.1 (0.1-0.3) | <.0001 |
| NOD2/CARD15 genotype: wild type/risk allele | 0.3 (0.1-1.0) | .04 |
Type of gut decontamination, use of systemic antibiotics prior to ASCT, and NOD2/CARD15 polymorphism are independent parameters for low 3-IS levels (n = 126). Significance level <.05.
Abbreviations are explained in Tables 1 and 2.